Patricia del Río

Company: Mikrobiomik

Job title: Director of Business Development

Seminars:

First Non-Antibiotic Antibiotic: MBK-01 Capsules Compared to Fidaxomicin for the Treatment of Primary & Recurrent Clostridioides Difficile Infection 11:30 am

Presenting Phase 3 efficacy and safety data for MBK-01, a non-antibiotic therapy for Clostridioides difficile infection Exploring real-world evidence findings and insights from the compassionate use program Expanding clinical research efforts into new therapeutic areas for MBK-01Read more

day: Conference Day One, Track One, AM